STANDARDIZATION OF AYUSH MEDICINES

The Ministry of AYUSH outlines regulatory and quality‑assurance measures for AYUSH medicines, citing the Drugs & Cosmetics Act, 1940 and related rules that mandate licensing, GMP compliance (Schedule T, Schedule M‑I) and adherence to pharmacopoeial standards. Drug inspectors collect samples for testing in 34 state‑run and 118 private Drug Testing Laboratories, with non‑conforming products subject to legal action. The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) sets standards and acts as an appellate testing lab, while the Ayush Quality Mark, Ayush Standard Mark and Ayush Premium Mark certify compliance with national and international standards. Export performance data (2020‑2026) show the USA, Germany, Italy and other countries as major markets, and the ministry has signed 27 country‑to‑country MoUs and 57 institute‑level MoUs to promote international cooperation.